The Centers for Medicare & Medicaid Services has given pharmaceutical manufacturers an additional month to participate in a new initiative aimed at reducing prescription drug costs for low-income Americans. The application deadline has been pushed back from March 31 to April 30, 2026.
Federal health officials announced Monday they are giving pharmaceutical companies extra time to enroll in a groundbreaking program designed to bring down prescription drug costs for Americans receiving Medicaid benefits.
The Centers for Medicare & Medicaid Services has moved the application deadline from March 31 to April 30, 2026, for drug manufacturers interested in participating in the new payment structure.
The initiative aims to reduce medication expenses within the Medicaid system, which serves low-income individuals and families, bringing those costs in line with what other developed countries pay for prescription drugs.
Major Argentine Union Challenges President’s Labor Law Changes in Court
Missouri Farmer Warns of Brazil’s Growing Threat to U.S. Corn Market
Schools Face Hurdles Bringing Whole Milk Back to Cafeteria Menus
Michigan Farm Bureau: Deer Population Control Efforts Need More Focus